| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/23/2011 | EP2287162A1 Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of cns disorders |
| 02/23/2011 | EP2287161A1 Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of cns disorders |
| 02/23/2011 | EP2287160A1 Novel benzothiophene oxide derivative and salt thereof |
| 02/23/2011 | EP2287147A2 2-Amino-bicyclo[3.1.0]hexane-2,6-dicarboxylic ester derivative |
| 02/23/2011 | EP2286875A1 Use of ansamycins for treatment or prevention of Alzheimer's Disease |
| 02/23/2011 | EP2286830A2 Composition comprising vlp and amyloid-beta peptide |
| 02/23/2011 | EP2286828A1 Ameliorating agent for neurogenic pain |
| 02/23/2011 | EP2286811A1 Chemokine receptor antagonists and methods of use thereof |
| 02/23/2011 | EP2286803A1 Use of alpha1 adrenergic receptor antagonists for treatment or prevention of Alzheimer's Disease |
| 02/23/2011 | EP2286801A2 Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof |
| 02/23/2011 | EP2286793A2 Pharmaceutical formulations comprising cannabidiol |
| 02/23/2011 | EP2285798A1 Muscarinic receptor agonits useful in the treatment of pain, alzheimer's disease and schizophrenia |
| 02/23/2011 | EP2285787A2 3-substituted propanamine compounds |
| 02/23/2011 | EP2285784A1 1-(arylsulfonyl)-4-(piperazin-1-yl)-1h-benzimidazoles as 5-hydroxytryptamine-6 ligands |
| 02/23/2011 | EP2285783A1 Indazole compounds as ccr1 receptor antagonists |
| 02/23/2011 | EP2285780A1 Processes and compounds for the preparation of normorphinans |
| 02/23/2011 | EP2285395A2 Molecules interfering with binding of calbindin to inositol monophosphatase for the treatment of mood disorders |
| 02/23/2011 | EP2285386A1 Use of ribose in lessening the clinical symptoms of aberrant firing of neurons |
| 02/23/2011 | EP2285377A1 Method for treating cognitive deficits |
| 02/23/2011 | EP2285374A1 Combination compositions for treating alzheimer disease and related disorders with zonisamide and acamprosate |
| 02/23/2011 | EP2285373A2 Treatment of organophosphate exposure with tetrahydroindolone arylpiperazine compounds |
| 02/23/2011 | EP2285372A2 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 02/23/2011 | EP2285369A2 Sulfobetaines for cancer, obesity, macular degeneration, neurodegenerative diseases |
| 02/23/2011 | EP2285365A1 Use of a composition comprising at least one beta-blocker for the treatment of sleep disorders |
| 02/23/2011 | EP2285217A1 Compounds for improving learning and memory |
| 02/23/2011 | EP2155731B1 1, 3-dihydroimidazole- 2 -thione derivatives as inhibitors of dopamine-beta-hydroxylase |
| 02/23/2011 | EP1919907B1 Heterocyclic compound |
| 02/23/2011 | EP1805164B1 6-(pyridinyl)-4-pyrimidone derivates as tau protein kinase 1 inhibitors |
| 02/23/2011 | EP1799306B1 Compositions and methods for treating cognitive disorders |
| 02/23/2011 | EP1656358B1 Stable polymorph of bifeprunox mesilate |
| 02/23/2011 | EP1643985B1 The combination of a serotonin reuptake inhibitors and agomelatine |
| 02/23/2011 | EP1617218B1 METHOD OF SCREENING DRUG WITH THE USE OF 67 kDa LAMININ RECEPTOR |
| 02/23/2011 | EP1610791B1 Implantable polymeric device for sustained release of dopamine agonist |
| 02/23/2011 | EP1524998B1 Stable aqueous pharmaceutical composition comprising erythropoietin |
| 02/23/2011 | EP1448550B1 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with tnf activity |
| 02/23/2011 | EP1268096B2 Extrusion die |
| 02/23/2011 | CN1751042B Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors |
| 02/23/2011 | CN101981443A Method of bioassaying yokukansan |
| 02/23/2011 | CN101981053A Pegylated Abeta FAB |
| 02/23/2011 | CN101981039A Substituted heteroarylamide oxazepinopyrimidone derivatives |
| 02/23/2011 | CN101981032A Substituted arylamide diazepinopyrimidone derivatives for the treatment of neurodegenerative diseases caused by abnormal activity of GSK3-beta |
| 02/23/2011 | CN101981031A Tricyclic compounds having corticotropin-releasing factor antagonistic activity and pharmaceutical compositions containing them |
| 02/23/2011 | CN101981027A Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses |
| 02/23/2011 | CN101981026A Derivatives of tetrahydroquinoxaline urea, preparation thereof and therapeutic application thereof |
| 02/23/2011 | CN101981025A Diarylmethylamide derivative having antagonistic activity on melanin-concentrating hormone receptor |
| 02/23/2011 | CN101981023A Process for the preparation of benzo-fused heteroaryl derivatives |
| 02/23/2011 | CN101981019A Process for the preparation of benzo-fused heteroaryl sulfamates and crystalline form of n-( ( (2s) -6-chloro-2,3-dihydro-l,4-benzodioxin-2-yl) methyl-sulfamide |
| 02/23/2011 | CN101981010A 酰胺化合物 Amide compounds |
| 02/23/2011 | CN101980726A Methods and means for treating DNA repeat instability associated genetic disorders |
| 02/23/2011 | CN101979510A Bone marrow derived neural stem cell for expressing chemotactic factor receptor CCR5 and preparation method thereof |
| 02/23/2011 | CN101979412A IL-18 binding proteins |
| 02/23/2011 | CN101979382A Aminoindazole derivatives and use thereof as kinase inhibitors |
| 02/23/2011 | CN101979095A Treatment and diagnosis of macrophage mediated disease |
| 02/23/2011 | CN101979093A Composition comprising polypeptide-drug substance and other poorly absorbed active ingredient and its use |
| 02/23/2011 | CN101979087A Health liquor and preparation method thereof |
| 02/23/2011 | CN101979077A Traditional Chinese medicine for treating heart cerebrovascular diseases |
| 02/23/2011 | CN101979050A Traditional Chinese medicine for treating diabetic peripheral neuropathy |
| 02/23/2011 | CN101979042A Traditional Chinese medicament for treating diabetic peripheral neuropathy |
| 02/23/2011 | CN101979039A Medicine for treating mental disease |
| 02/23/2011 | CN101979037A Medicament for treating diabetic complications and preparation method thereof |
| 02/23/2011 | CN101979024A Medicament for treating heart and cerebrovascular diseases, intervertebral disc herniation, cervical spondylosis or hemiplegia |
| 02/23/2011 | CN101978990A Schisandra extract and preparation method and application thereof |
| 02/23/2011 | CN101978988A Chinese medicament aroma agent for promoting human memory |
| 02/23/2011 | CN101978979A Method for preparing refined celery extract |
| 02/23/2011 | CN101978975A Haematococcus extract preparation, and preparation method and use thereof |
| 02/23/2011 | CN101978974A Method for extracting bioactive substance by breaking walls of chlorella pyrenoidosa chick |
| 02/23/2011 | CN101978950A Alpha-linolenic acid ester fat emulsion injection and preparation method thereof |
| 02/23/2011 | CN101978949A Gamma-linolenate fat emulsion intravenous injection and preparation method thereof |
| 02/23/2011 | CN101133064B Substituted oxa-diaza-spiro-[5.5]-undecanone derivatives and their use as neurokinin antagonists |
| 02/23/2011 | CN101073647B Medicinal composition for treating chronic cephalalgia and its making method |
| 02/23/2011 | CN101058608B Human anti-Abeta(1-32) amyloid antibody, purifying method and use thereof |
| 02/22/2011 | US7894769 Wireless microphone communication system |
| 02/22/2011 | US7893279 Cyclohexanecarboxylic acid compound |
| 02/22/2011 | US7893209 Slo2, novel potassium channel proteins from human brain |
| 02/22/2011 | US7893204 Attractin/mahogany-like polypeptides |
| 02/22/2011 | US7893105 Levodopa prodrug mesylate, compositions thereof, and uses thereof |
| 02/22/2011 | US7893090 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 02/22/2011 | US7893079 Substituted monocyclic CGRP receptor antagonists |
| 02/22/2011 | US7893054 Materials and methods relating to protein aggregation in neurodegenerative disease |
| 02/22/2011 | US7893052 CGRP receptor antagonists |
| 02/22/2011 | US7893051 Thiophenyl and pyrrolyl azepines as serotonin 5-HT2c receptor ligands and uses thereof |
| 02/22/2011 | US7893036 In vivo production of small interfering RNAs that mediate gene silencing |
| 02/22/2011 | US7892560 Clostridial toxin derivatives able to modify peripheral sensory afferent functions |
| 02/22/2011 | US7892556 Apoptotically active peptides |
| 02/22/2011 | US7892545 Humanized antibodies that sequester amyloid beta peptide |
| 02/22/2011 | US7892531 Human serum albumin(HSA); solubilized in low-ionic-strength buffer with specified ph; glycine, aspartic acid, sodium succinate, trehalose; binds with receptors |
| 02/22/2011 | CA2540678C Pharmaceutical compositions for prevention of overdose or abuse |
| 02/22/2011 | CA2510096C Method for the production of crystalline forms and crystalline forms of optical enantiomers of modafinil |
| 02/22/2011 | CA2486378C Preparation and application of total salvianolic acid |
| 02/22/2011 | CA2484159C Heteroaryl substituted spirocyclic sulfamides for inhibition of gamma secretase |
| 02/22/2011 | CA2476296C Amino-derivatives as inhibitors of histone deacetylase |
| 02/22/2011 | CA2474823C Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one derivatives |
| 02/22/2011 | CA2470575C Spiroazacyclic compounds as monoamine receptor modulators |
| 02/22/2011 | CA2446314C Liver x receptor agonists |
| 02/22/2011 | CA2444062C Novel use of 2h-benzimidazol-2-one,1,3-dihydro-1-(2{4-[3-(trifluoromethyl)phenyl]-1-piperazinyl}ethyl)- and its physiologically acceptable acid addition salts |
| 02/22/2011 | CA2410193C Neuronal serine-threonine protein kinase |
| 02/22/2011 | CA2328438C Heterocyclically substituted amides, their production and their use |
| 02/22/2011 | CA2319198C Substituted oxoazaheterocyclyl factor xa inhibitors |
| 02/17/2011 | WO2011020061A2 Compositions and methods of for treating bipolar disorder |
| 02/17/2011 | WO2011020030A2 Methods and compositions to prevent addiction |